Logo

NeuMoDx 288 and NeuMoDx 96 Molecular Systems

Oct 31, 2018
NeuMoDx Molecular has launched the NeuMoDx 288 Molecular System and the NeuMoDx 96 Molecular System in the US. The 288 system loads up to 288 patient samples and has been cleared by the US Food and Drug Administration, while the 96-sample instrument is registered with the FDA for lab-developed testing use. Both instruments are PCR-based and enable continuous, random-access, sample-to-results workflows for on-demand, high-throughput sample processing with an operator walkaway window of up to eight hours. The systems use the firm's proprietary NeuDry reagents which require no refrigeration and have an on-board stability of up to 60 days and room temperature shelf life of more than one year. The instrument can run NeuMoDx's growing menu of infectious disease and sexually transmitted infections assays, as well as LDTs using the company's general-purpose reagents and consumables.
Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.